These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

594 related items for PubMed ID: 28449624

  • 1. An economic analysis of tolvaptan compared with fluid restriction among hospitalized patients with hyponatremia.
    Ramamohan V, Mladsi D, Ronquest N, Kamat S, Boklage S.
    Hosp Pract (1995); 2017 Aug; 45(3):111-117. PubMed ID: 28449624
    [Abstract] [Full Text] [Related]

  • 2. Economic impact of tolvaptan treatment vs. fluid restriction based on real-world data among hospitalized patients with heart failure and hyponatremia.
    Dasta JF, Sundar S, Chase S, Lingohr-Smith M, Lin J.
    Hosp Pract (1995); 2018 Oct; 46(4):197-202. PubMed ID: 30045645
    [Abstract] [Full Text] [Related]

  • 3. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH, Bohm NM, Nemecek BD, Crawford R, Kelley D, Bhasin B, Nietert PJ, Velez JCQ.
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of costs associated with tolvaptan-mediated hospital length of stay reduction among US patients with the syndrome of inappropriate antidiuretic hormone secretion, based on SALT-1 and SALT-2 trials.
    Dasta JF, Chiong JR, Christian R, Lin J.
    Hosp Pract (1995); 2012 Feb; 40(1):7-14. PubMed ID: 22406878
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
    Jamookeeah C, Robinson P, O'Reilly K, Lundberg J, Gisby M, Ländin M, Skov J, Trueman D.
    BMC Endocr Disord; 2016 May 16; 16(1):22. PubMed ID: 27184496
    [Abstract] [Full Text] [Related]

  • 6. SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan.
    De Las Peñas R, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Álvarez Y, Rodríguez CA, Virizuela JA, López López R.
    Support Care Cancer; 2016 Jan 16; 24(1):499-507. PubMed ID: 26431960
    [Abstract] [Full Text] [Related]

  • 7. Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
    Vaghasiya RP, DeVita MV, Michelis MF.
    Int Urol Nephrol; 2012 Jun 16; 44(3):865-71. PubMed ID: 21607553
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of tolvaptan for euvolemic or hypervolemic hyponatremia.
    Lee MY, Kang HJ, Park SY, Kim HL, Han E, Lee EK.
    Clin Ther; 2014 Sep 01; 36(9):1183-94. PubMed ID: 25151571
    [Abstract] [Full Text] [Related]

  • 9. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ, Ahmad F, Blais JD, Chiodo J, Zhou W, Glaser LA, Czerwiec FS.
    Cancer Med; 2017 Apr 01; 6(4):723-729. PubMed ID: 28251822
    [Abstract] [Full Text] [Related]

  • 10. Randomized, double blinded, placebo-controlled trial to evaluate the efficacy and safety of tolvaptan in Chinese patients with hyponatremia caused by SIADH.
    Chen S, Zhao JJ, Tong NW, Guo XH, Qiu MC, Yang GY, Liu ZM, Ma JH, Zhang ZW, Gu F.
    J Clin Pharmacol; 2014 Dec 01; 54(12):1362-7. PubMed ID: 24906029
    [Abstract] [Full Text] [Related]

  • 11. Current Management of Hyponatremia in Acute Heart Failure: A Report From the Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (HN Registry).
    Dunlap ME, Hauptman PJ, Amin AN, Chase SL, Chiodo JA, Chiong JR, Dasta JF.
    J Am Heart Assoc; 2017 Aug 03; 6(8):. PubMed ID: 28775063
    [Abstract] [Full Text] [Related]

  • 12. [The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
    Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, Poch E, European Hyponatremia Network.
    Med Clin (Barc); 2013 Dec 07; 141(11):507.e1-507.e10. PubMed ID: 24169317
    [Abstract] [Full Text] [Related]

  • 13. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
    Estilo A, McCormick L, Rahman M.
    Adv Ther; 2021 Dec 07; 38(12):5721-5736. PubMed ID: 34693505
    [Abstract] [Full Text] [Related]

  • 14. [The use of tolvaptan in a case of severe hyponatriemia in SIADH during meningitis].
    Rollino C, Balbiano R, Caramello P, Roccatello D.
    G Ital Nefrol; 2013 Dec 07; 30(6):. PubMed ID: 24402662
    [Abstract] [Full Text] [Related]

  • 15. Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia.
    Amin AN, Ortendahl JD, Harmon AL, Kamat SA, Stellhorn RA, Chase SL, Sundar SV.
    Curr Med Res Opin; 2018 Mar 07; 34(3):559-566. PubMed ID: 29297709
    [Abstract] [Full Text] [Related]

  • 16. Tolvaptan Treatment in Children with Chronic Hyponatremia due to Inappropriate Antidiuretic Hormone Secretion: A Report of Three Cases.
    Tuli G, Tessaris D, Einaudi S, De Sanctis L, Matarazzo P.
    J Clin Res Pediatr Endocrinol; 2017 Sep 01; 9(3):288-292. PubMed ID: 28515029
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, Poch E.
    Nefrologia; 2014 Sep 01; 34(4):439-50. PubMed ID: 25036057
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial.
    Chiong JR, Kim S, Lin J, Christian R, Dasta JF.
    J Med Econ; 2012 Sep 01; 15(2):276-84. PubMed ID: 22111754
    [Abstract] [Full Text] [Related]

  • 19. Comparison of tolvaptan treatment between patients with the SIADH and congestive heart failure: a single-center experience.
    Park GH, Lee CM, Song JW, Jung MC, Kim JK, Song YR, Kim HJ, Kim SG.
    Korean J Intern Med; 2018 May 01; 33(3):561-567. PubMed ID: 28286940
    [Abstract] [Full Text] [Related]

  • 20. Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
    Nakamura M, Sunagawa O, Kugai T, Kinugawa K.
    Int Heart J; 2017 Dec 12; 58(6):1004-1007. PubMed ID: 29151494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.